APPROVALS

A new clinical trial collaboration will evaluation the combination of AbbVie’s investigational antibody drug conjugate ABBV-399 and Bristol-Myers Squibb’s immunotherapy Opdivo in c-Met overexpressing...

Amryt Pharma has raised £13.3 million through share placing to fund its ongoing Phase III trial of AP101. AP101 is a potential treatment for Epidermolysis...

There are 87 potential new treatments in clinical trials for Alzheimer’s disease, according to Pharmaceutical Research and Manufacturers of America (PhRMA). Current research is focused...